Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Biocon Ltd.
NSE: BIOCON
|
BSE: 532523
|
ISIN: INE376G01013
|
Industry: Biotechnology
US FDA Approval
|
Mid-range Performer
415.5500
3.05
(
0.74
%)
NSE
Aug 21, 2026
15:31 PM
Volume:
2.2M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Biocon Ltd.
29 Nov 2025
US FDA Approval
415.55
0.74%
Pick of the Week:Biocon
Buy:
Biocon Ltd.
by
Axis Direct
Target: 440 | Target met
Target
Axis Direct
BUY with a target price of Rs 440, implying an upside of ~10% from the CMP.
Biocon Ltd. is trading
above its 200 day SMA
of 395.2
More from Biocon Ltd.
Recommended
Five Interesting Stocks Today - August 21, 2026
The Baseline |
21 Aug 2026, 04:40PM
Market closes flat as investors turn cautious after Trump’s Iran sanctions announcement
Trendlyne Marketwatch |
21 Aug 2026, 04:01PM
A long drawn out R&D plan may be finally paying off for Biocon
|
20 Aug 2020, 08:47AM